The regenerative medicine field could experience explosive growth, from $1.6 billion to $15 to $20 billion over the next 15 years, according to Scientia Advisors' new market review.
The short-term focus in the area is on specific, practical clinical applications, such as Medtronic's spine fusion applications involving bone morphogenetic protein to spur bone growth. BMP can simplify spinal surgery by reducing the number of procedures required.
Scientia also predicts growth in peripheral...